Demand Surges for Capping Medical Device Markups Following Anti-Cancer Drug Price Cap, ETHealthworld
Mumbai: A day after the National Pharmaceutical Pricing Authority (NPPA) approved a cap on the markup of anti-cancer drugs at 30 per cent of their MRP, the Association of Indian Medical Device Industry (AiMeD) has pushed for a similar measure to rationalise markup on medical devices. AiMeD said that while it has always backed trade…
